This double-blind, randomized controlled trial assessed the impact of oral magnesium chloride (2.5 g/day) for three months on beta-cell function in 106 non-diabetic, normotensive adults with hypomagnesemia. The magnesium group showed a significant increase in the area under the curve (AUC) for the hyperbolic model of beta-cell function—from 7.591 to
